CSPCY.US CSPC Pharmaceutical Group Limited

Healthcare Pharmaceuticals USA Stocks
4.05 USD
Close of Nov 14, 2026
3.32 5.25
Market cap
USD 11.5B
P/E
10.9x
P/B
2.18x
ROE
64.1%
Dividend yield
3.90%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is CSPCY.US undervalued?

Graham number
Price4.05
Graham value3.93
Premium3.0%

CSPCY.US trades 3.0% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CSPC Pharmaceutical Group Limited fundamental analysis

No fundamental analysis for CSPC Pharmaceutical Group Limited yet.

CSPC Pharmaceutical Group Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enx…

Full company profile